Community articles
Plain-language guides on medications, conditions and everyday care, to read before you talk with your prescriber or pharmacist.
How to Get a Synjardy Savings Card and Check Eligibility
If you want to know how to get a Synjardy savings card, start with the official manufacturer savings program, answer the eligibility…
Read more →
Synjardy 12.5 mg/1000 mg Uses, Safety, and Monitoring
Synjardy 12.5 mg/1000 mg uses include helping adults with type 2 diabetes improve blood sugar control when diet, exercise, and medication planning…
Read more →
Synjardy in Type 2 Diabetes: Uses, Risks, and Monitoring
Synjardy is used with diet and exercise to help improve blood sugar control in people with type 2 diabetes. If you are…
Read more →
Synjardy Weight Loss: Safety, Limits, and Expectations
Synjardy weight loss can happen in some adults with type 2 diabetes, but Synjardy is not approved as a weight-loss treatment. The…
Read more →
Synjardy Side Effects: Symptoms, Risks, and Red Flags
Synjardy side effects can include stomach upset, diarrhea, nausea, urinary tract infections, genital yeast infections, headache, weakness, and low blood sugar, especially…
Read more →
When Will Retatrutide Be Available? Trials and U.S. Access
Retatrutide is not available as an FDA-approved prescription medicine in the United States. If you are asking when will Retatrutide be available,…
Read more →
How Does Retatrutide Work? Appetite and Metabolism
The question 'how does Retatrutide work' has a short answer: retatrutide is being studied as a triple receptor agonist that activates GLP-1,…
Read more →
Retatrutide Side Effects: Safety Signals and Trial Cautions
Retatrutide side effects reported so far are mainly gastrointestinal, including nausea, vomiting, diarrhea, constipation, and reduced appetite. The bigger safety issue is…
Read more →
Retatrutide Dosing for Weight Loss: Research and Safety
Current research does not support a standard prescribing dose for retatrutide, because it remains an investigational drug. Retatrutide dosing for weight loss…
Read more →
Retatrutide Peptide: Safety, Trials, and Access Questions
Retatrutide peptide is an investigational metabolic drug candidate, not an approved prescription treatment. Researchers are studying it for obesity and type 2…
Read more →
Semaglutide for Hidradenitis Suppurativa: Evidence and Safety
Semaglutide for hidradenitis suppurativa is an emerging idea, not an approved HS treatment. Early reports suggest it may help some people with…
Read more →
Apixaban Nursing Considerations: Safety, Monitoring, and Teaching
Direct oral anticoagulants change bedside routines, and apixaban is no exception. Effective assessment, clear documentation, and targeted teaching reduce preventable harm. This…
Read more →Browse by medical condition
Products and reading lists grouped by condition, from A to Z.
All medical conditions →Looking for a medication?
Prices in USD, shown before you pay. Prescription required.
Shop all medications →Disclaimer: The content on Canadian Insulin is provided for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified healthcare provider with any questions you may have about a medical condition, medication, or treatment plan. If you think you may be experiencing a medical emergency, call 911 or go to the nearest emergency room immediately.